This water-soluble compound (dimethylaminomicheliolide) exhibits a higher plasma stability than parthenolide and was found to target glioma stem-like cells through regulation of the protein AEBP1 (adipocyte enhancer binding protein 1) [146]. Here, AEBP1 is linked to central nervous system cancer.